Key result
Central aortic systolic blood pressure and augmentation index measured using the Vasotens device equated significantly with parameters measured by the validated SphygmoCor system.
Why the study?
Does Vasotens technology provide comparable central aortic blood pressure and augmentation index measurements to the validated SphygmoCor system in patients and healthy volunteers?
Cross-Sectional (n=160)
Yes
Does Vasotens technology provide comparable central aortic blood pressure and augmentation index measurements to the validated SphygmoCor system in patients and healthy volunteers?
The Vasotens oscillometric method provides valid measurements of central aortic blood pressure and augmentation index comparable to the established SphygmoCor tonometric system.
May support Vasotens as SphygmoCor alternative; leaves open prospective validation before wider use.
Introduction: The aim of this study is the comparison of Vasotens ® technology as used in a device with an oscillometric method of blood pressure measurement (BPLab, Petr Telegin Ltd, Nizhny Novgorod, Russian Federation) against the validated tonometric system (SphygmoCor ® , AtCor Medical Pty Ltd, West Ryde, Australia). Methods: The examinations were carried out in two medical centers. Exclusion criteria included atrial fibrillation, severe cardiac anomalies, heart failure, arrhythmia, decompensated diabetes, the presence of an artificial pacemaker, pregnancy, and BMI > 30. Overall, 160 patients and healthy volunteers were examined. Central aortic systolic blood pressure (aSBP) and augmentation index (aAIx) were obtained by means of applanation tonometry and the oscillometric method was compared. Results: aSBP and aAIx measured using the BPLab device equates significantly with the same parameters measured by SphygmoCor. Conclusion: This finding allows the recommendation of Vasotens technology, which can be used with the 24-hour BPLab monitoring system for wide clinical use.
No takes yet. Share an insight, caveat, or question.
Рогоза et al. (2012) reported a cross-sectional. Vasotens technology (BPLab) vs. SphygmoCor tonometric system was evaluated on Central aortic systolic blood pressure (aSBP) and augmentation index (aAIx). Central aortic systolic blood pressure and augmentation index measured using the Vasotens device equated significantly with parameters measured by the validated SphygmoCor system.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: